Carlo L. Yuen

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.

Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.

Journal: BJUI compass

Published: February 11, 2025

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Journal: BJU international

Published: October 20, 2023

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: September 12, 2022

Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy.

Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy.

Journal: Pathology

Published: September 12, 2022

Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.

Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.

Journal: The Journal of urology

Published: August 10, 2022

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: July 02, 2020

The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.

The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.

Journal: The Journal of urology

Published: December 12, 2019

Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.

Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.

Journal: BJU international

Published: July 10, 2019

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

Journal: The British journal of radiology

Published: December 20, 2018

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50.

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50.

Journal: Research and reports in urology

Published: October 17, 2018

Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.

Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.

Journal: BJU international

Published: October 11, 2018

Early Experience in Da Vinci Robot-Assisted Partial Nephrectomy: An Australian Single Centre Series.

Early Experience in Da Vinci Robot-Assisted Partial Nephrectomy: An Australian Single Centre Series.

Journal: Minimally invasive surgery

Published: March 21, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026